Every year, thousands of heart attack victims are sent home without treatment by emergency-room doctors because tests don’t show clear signs of a problem, such as elevated levels of proteins released into the blood by dying heart cells. But an ultrasensitive detector, expected to be widely available for clinical evaluation later this year, could save lives by recognizing those proteins at a thousandth the concentration that current methods can detect – or even less. The device, built by Nanosphere of Northbrook, IL, is based on research by Northwestern University chemist Chad Mirkin, who developed a way to coat gold nanoparticles with selectively “sticky” substances, such as DNA strands constructed to bind with complementary target DNA in a sample. When the nano-particles, stuck to their targets, attach to a microarray that also bears complementary DNA, a digital camera can scan them to find the sample’s DNA concentration. A similar method, using antibodies as the glue, can measure protein concentrations.
Clinical trials are now testing techniques that could be used to diagnose previously undetected heart disease and Alzheimer’s disease. Nanosphere’s CEO, Bill Moffitt, says the device could reveal levels of telltale Alzheimer’s proteins in the blood at concentrations “undetectable by any other technology.”
This startup wants to copy you into an embryo for organ harvesting
With plans to create realistic synthetic embryos, grown in jars, Renewal Bio is on a journey to the horizon of science and ethics.
VR is as good as psychedelics at helping people reach transcendence
On key metrics, a VR experience elicited a response indistinguishable from subjects who took medium doses of LSD or magic mushrooms.
This artist is dominating AI-generated art. And he’s not happy about it.
Greg Rutkowski is a more popular prompt than Picasso.
This nanoparticle could be the key to a universal covid vaccine
Ending the covid pandemic might well require a vaccine that protects against any new strains. Researchers may have found a strategy that will work.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.